Qinecsa Chief Operating Officer, John Cogan, has been featured in European Pharmaceutical Manufacturer latest issue, where he predicts where is the industry setting its sights for
Ongoing drug safety monitoring is critical to containing risk and keeping patients safe, and with so many channels for reporting adverse events, the workload in
Beena Wood, a drug safety specialist and chief product officer at Qinecsa Solutions, says 2025 has seen a reality check in this regard. In a pharmacovigilance
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharma Time’s latest issue, where she reflects on the importance of groundwork before forging ahead
When Aurinia Pharmaceuticals launched their first FDA-approved product, LUPKNIS© (voclosporin), they recognised the need for a modern, scalable PV infrastructure. Reportum© was deployed which has
A global top-5 pharmaceutical company launched a groundbreaking therapy in one of it’s largest markets. Due to the success of the blockbuster drug, the team
Our client; a top-50 holistic healthcare company headquartered in Japan, globally markets several pharmaceuticals and nutraceuticals. Their challenge included processing cases from local affiliates worldwide
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in European Pharmaceutical Contractor’s latest issue, where he discusses that using statistical methods in signal
Qinecsa Chief Operating Officer, John Cogan, has been featured in Chimica Oggi Chemistry Today’s latest issue, where he discusses the impact of new therapy areas
Qinecsa VP Product Management QVW, Jonathan Messer, has been featured in Drug Discovery World’s latest issue, where he discusses that the rise in global regulatory
